Feedback from our readers
Search results for: anticoagulant
Drug Updates
Information on new approvals and medication safety
Drug UPDATES
Information on New Approvals and Medication Safety
A Catalyst for Antiphospholipid Syndrome Research
APS ACTION is coordinating international efforts to study this rare and potentially fatal autoimmune disorder
Tracking Patient Manifestations of Behçet’s Syndrome around the World
Tracking patient manifestations of Behçet’s syndrome around the world
Hypercoagulable States in Rheumatic Disease
Prevention and management strategies continue to evolve
Antiphospholipid Syndrome
Antiphospholipid syndrome (APS) is an autoimmune disease associated with frequent clotting in arteries and veins and fetal losses. The clotting results from the presence of proteins in the blood—called antiphospholipid autoantibodies (aPL)—formed against the person’s own tissues.
A Better Family Plan
How to minimize the risks of pregnancy for women with SLE
Reading Rheum
Handpicked Reviews of Contemporary Literature
Antiphospholipid Antibody Syndrome
A recently identified autoimmune disorder, antiphospholipid antibody syndrome (APS) mainly affects young women between age 30 and 40. Those affected by APS may otherwise be healthy or have an underlying disease such as systemic lupus erythematosus (SLE).
- « Previous Page
- 1
- …
- 7
- 8
- 9
- 10
- Next Page »